JP2011045473A5 - - Google Patents

Download PDF

Info

Publication number
JP2011045473A5
JP2011045473A5 JP2009195275A JP2009195275A JP2011045473A5 JP 2011045473 A5 JP2011045473 A5 JP 2011045473A5 JP 2009195275 A JP2009195275 A JP 2009195275A JP 2009195275 A JP2009195275 A JP 2009195275A JP 2011045473 A5 JP2011045473 A5 JP 2011045473A5
Authority
JP
Japan
Prior art keywords
calcium
mixture
powder
group
phosphoric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009195275A
Other languages
Japanese (ja)
Other versions
JP5210266B2 (en
JP2011045473A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2009195275A priority Critical patent/JP5210266B2/en
Priority claimed from JP2009195275A external-priority patent/JP5210266B2/en
Publication of JP2011045473A publication Critical patent/JP2011045473A/en
Publication of JP2011045473A5 publication Critical patent/JP2011045473A5/ja
Application granted granted Critical
Publication of JP5210266B2 publication Critical patent/JP5210266B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (10)

ポリマーを含有するケイ酸カルシウム系骨用セメントを製造する方法であって、
(a)カルシウム塩をケイ素化合物と混合する工程であって、前記カルシウム塩が、酸化カルシウム、水酸化カルシウム、酢酸カルシウム、および塩化カルシウムからなる群より選択され、前記ケイ素化合物が、二酸化ケイ素および四酢酸ケイ素からなる群より選択されるものである工程
(b)工程(a)の混合物をゾルゲル法で処理する工程
(c)工程(b)の混合物を加熱する工程
(d)工程(c)の混合物に、塑性を増すために、総質量に対して2〜30質量%の範囲でゼラチンを添加する工程
(e)工程(d)の混合物を粉末に粉砕する工程;および
(f)前記粉末を水またはリン酸溶液に添加する工程、
有してなる方法。
A method for producing a calcium silicate bone cement containing a polymer,
(A) a step of mixing a calcium salt with a silicon compound , wherein the calcium salt is selected from the group consisting of calcium oxide, calcium hydroxide, calcium acetate and calcium chloride; A step selected from the group consisting of silicon acetate ;
(B) treating the mixture with a sol-gel method step (a);
(C) heating the mixture of step (b);
(D) the mixture of step (c), in order to increase the plasticity, adding gelatin in the range of 2 to 30% by weight relative to the total weight;
(E) a step of grinding the mixture of step (d) in powder; and (f) adding pre-Symbol powder in water or phosphoric acid solution,
A method comprising :
前記混合物が、10から0.1に及ぶカルシウムのケイ素に対するモル比を有することを特徴とする請求項1記載の方法。   The method of claim 1, wherein the mixture has a molar ratio of calcium to silicon ranging from 10 to 0.1. 前記ゾルゲル法が、
(i)前記工程(a)からの混合物を、エタノールおよび硝酸からなる群より選択される希釈溶媒と1〜12時間に亘り混合し、
(ii)前記混合物を1〜7日間に亘り20〜100℃の温度に配置し、
(iii)前記混合物を−40〜150℃で乾燥させる、
各工程を含むことを特徴とする請求項1または2記載の方法。
The sol-gel method is
(I) mixing the mixture from step (a) with a diluent solvent selected from the group consisting of ethanol and nitric acid for 1-12 hours;
(Ii) placing the mixture at a temperature of 20-100 ° C. for 1-7 days;
(Iii) drying the mixture at −40 to 150 ° C .;
The method according to claim 1 or 2 , comprising each step.
前記加熱工程が、
(i)前記工程(b)からの混合物を1〜40℃/分の速度で700〜1300℃に加熱し、
(ii)前記混合物を700〜1300℃の定温範囲に維持し、
(iii)前記混合物を、空冷、水冷または高速冷却技法によって室温まで冷却して、ケイ酸カルシウム粉末を得る、
各工程を含むことを特徴とする請求項1から3いずれか1項記載の方法。
The heating step is
(I) heating the mixture from step (b) to 700-1300 ° C at a rate of 1-40 ° C / min;
(Ii) maintaining the mixture in a constant temperature range of 700-1300 ° C;
(Iii) cooling the mixture to room temperature by air cooling, water cooling or fast cooling techniques to obtain a calcium silicate powder;
3 any one method according to claim 1, characterized in that it comprises the steps.
前記粉砕工程が、
(i)前記ゼラチンを含有する前記ケイ酸カルシウム粉末をアルコールと混合し、
(ii)前記粉末をボールミル粉砕機で0.5〜3日間に亘り粉砕し、
(iii)前記粉末を−40〜60℃で乾燥させる、
各工程を含むことを特徴とする請求項1から4いずれか1項記載の方法。
The grinding step
(I) mixing the calcium silicate powder containing the gelatin with alcohol;
(Ii) grinding the powder with a ball mill for 0.5 to 3 days;
(Iii) drying the powder at −40-60 ° C.,
4 any one method according to claim 1, characterized in that it comprises the steps.
前記粉末の水またはリン酸溶液に対する比が、1g/0.3〜2mlであることを特徴とする請求項1から5いずれか1項記載の方法。 The method according to any one of claims 1 to 5, wherein the ratio of the powder to water or phosphoric acid solution is 1 g / 0.3 to 2 ml. 前記リン酸溶液が、リン酸イオン(PO4 3-)、リン酸水素イオン(HPO4 2-)またはリン酸二水素イオン(H2PO4 -)から選択される陰イオンを含有することを特徴とする請求項1から6いずれか1項記載の方法。 The phosphoric acid solution contains an anion selected from phosphate ion (PO 4 3− ), hydrogen phosphate ion (HPO 4 2− ), or dihydrogen phosphate ion (H 2 PO 4 ). 7. A method according to any one of claims 1 to 6, characterized in that it is characterized in that 前記リン酸溶液が、アンモニウム、またはIA族の元素から選択される陽イオンを含有することを特徴とする請求項1から7いずれか1項記載の方法。 The method according to any one of claims 1 to 7 , wherein the phosphoric acid solution contains a cation selected from ammonium or a group IA element. ポリマーを含有するリン酸カルシウム骨用セメントのための組成物であって、
(a)酸化カルシウム、水酸化カルシウム、酢酸カルシウム、および塩化カルシウムからなる群より選択されるカルシウム塩、
(b)二酸化ケイ素および四酢酸ケイ素からなる群より選択されるケイ素化合物、
(c)総質量に対して2〜30質量%の範囲のゼラチン、および
(d)薬理学的に許容される溶液、
を含ことを特徴とする組成物。
A composition for a calcium phosphate bone cement containing a polymer comprising:
(A) a calcium salt selected from the group consisting of calcium oxide, calcium hydroxide, calcium acetate, and calcium chloride ;
(B) a silicon compound selected from the group consisting of silicon dioxide and silicon tetraacetate ,
(C) gelatin in the range of 2-30% by weight relative to the total weight , and (d) a pharmacologically acceptable solution,
Composition characterized in including things.
前記薬理学的に許容される溶液が、水、塩化ナトリウム溶液、塩化カルシウム溶液またはリン酸溶液であることを特徴とする請求項記載の組成物。 The composition according to claim 9, wherein the pharmacologically acceptable solution is water, sodium chloride solution, calcium chloride solution or phosphoric acid solution.
JP2009195275A 2009-08-26 2009-08-26 Calcium silicate composite cement and preparation method thereof Active JP5210266B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009195275A JP5210266B2 (en) 2009-08-26 2009-08-26 Calcium silicate composite cement and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009195275A JP5210266B2 (en) 2009-08-26 2009-08-26 Calcium silicate composite cement and preparation method thereof

Publications (3)

Publication Number Publication Date
JP2011045473A JP2011045473A (en) 2011-03-10
JP2011045473A5 true JP2011045473A5 (en) 2012-01-26
JP5210266B2 JP5210266B2 (en) 2013-06-12

Family

ID=43832413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009195275A Active JP5210266B2 (en) 2009-08-26 2009-08-26 Calcium silicate composite cement and preparation method thereof

Country Status (1)

Country Link
JP (1) JP5210266B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6432983B2 (en) * 2015-03-31 2018-12-05 株式会社松風 Medical and dental curable composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07112023A (en) * 1993-10-20 1995-05-02 Matsumoto Shika Univ Osteogenesis material
US20020037258A1 (en) * 1999-08-05 2002-03-28 Gregory P. Dodd Dental composition for the mineral occlusion of dentinal tubules in sensitive teeth
ATE295744T1 (en) * 2002-07-11 2005-06-15 Biomet Deutschland Gmbh METHOD FOR PRODUCING POROUS CALCIUM PHOSPHATE CHIPS AND GRANULES FROM GELATIN PROCESSING
GB0717516D0 (en) * 2007-09-07 2007-10-17 Imp Innovations Ltd Bioactive nanocomposite material

Similar Documents

Publication Publication Date Title
RU2016142392A (en) SURFACE-REHABILATED CALCIUM CARBONATE FOR REMINERALIZATION AND TEETH WHITENING
RU2011137960A (en) DRY POWDER COMPOSITIONS AND METHODS FOR TREATING PULMONARY DISEASES
CY1113676T1 (en) Substituted Beta-Finyl-Alpha-Hydroxy Propionic Acid, Method of Composition and Its Use
JP6792203B2 (en) Hydrogel-forming compositions and high-strength hydrogels made from them
JP2017535538A5 (en) 5-chloro-N4- [2- (dimethylphosphoryl) phenyl] -N2- {2-methoxy-4- [4- (4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2, Crystalline form of 4-diamine
JP2015151304A5 (en)
JP2016190843A5 (en)
JP2020517611A5 (en)
JP2012148089A5 (en)
HRP20200922T1 (en) Method for producing the crystalline form of modification a of calcobutrol
EP4321147A3 (en) Antiperspirant compositions
JP2008530065A5 (en)
JP2016215126A5 (en)
MY150070A (en) Pharmaceutically active compounds, their manufacture, compositions containing them and their use
JP2010523448A5 (en)
ES2654420T3 (en) Procedure for the manufacture of a pharmaceutical liquid preparation
DE60319375D1 (en) Double-coated lactic acid bacteria powder with protein and polysaccharide and the process for their preparation and their dosage form
JP2011045473A5 (en)
ITFI20060139A1 (en) NANOMETRIC HYDROXYPATITIS, ITS SUSPENSIONS PREPARATION AND USE.
JP2011503127A5 (en)
AR090187A1 (en) PROCEDURE FOR THE PREPARATION OF ENTERIC ALGINATE MICROCAPSULES BY IONIC GELATION CONTAINING DICLOFENAC OR ONE OF ITS SALTS AND MULTIPARTICULATE PHARMACEUTICAL COMPOSITION CONTAINING THEM
JP2018523644A5 (en)
Forizs et al. Thermal analysis of pure and multisubstituted hydroxyapatite pastes
EP2810917B1 (en) A method for producing calcium hydroxyapatite nano-crystals of the desired morphology
CN103183507A (en) Preparation method of biphase calcium phosphate ceramic containing beta-calcium pyrophosphate